基础医学与临床 ›› 2018, Vol. 38 ›› Issue (11): 1568-1571.

• 临床研究 • 上一篇    下一篇

Febuxostat对痛风伴高尿酸血症患者的血液流变学和血小板活化功能的影响

刘青员1,祁广东1,陈鑫2   

  1. 1. 江苏省滨海县人民医院
    2. 南通大学附属医院神经内科
  • 收稿日期:2018-02-06 修回日期:2018-07-06 出版日期:2018-11-05 发布日期:2018-11-22
  • 通讯作者: 刘青员 E-mail:bhxlqy@126.com

Effect of febuxostat on blood rheology and platelet activation in patients with gout and hyperuricemia

  • Received:2018-02-06 Revised:2018-07-06 Online:2018-11-05 Published:2018-11-22

摘要: 目的 探讨非布司他(febuxostat)对痛风伴高尿酸血症患者血液流变学及血小板活化功能的影响。方法 选取本院2015年4月至2017年3月收治的痛风伴高尿酸血症患者68例,随机分为对照组(35例)给予别嘌醇治疗,观察组(33例)给予Febuxostat治疗。比较两组患者的临床疗效、血液流变学变化以及血小板活化功能的变化。结果 观察组患者的治疗总有效率显著高于对照组患者(P<0.05),与对照组相比,观察组患者在治疗后的血液流变学指标改善和血小板活化功能改善均更为显著(P<0.05)。结论 Febuxostat治疗能有效降低痛风伴高尿酸血症患者的高尿酸状态,明显改善患者的血液流变学与血小板活化功能,疗效优于别嘌醇。

关键词: Febuxostat, 别嘌醇, 高尿酸血症, 痛风, 血液流变学, 血小板活化功能

Abstract: Objective To investigate the effect of febuxostat on blood rheology and platelet activation in patients with gout and hyperuricemia. Methods Sixty-eight cases of patients with gout and hyperuricemia were collected in our hospital from April 2015 to March 2017. They were randomly divided into the control group (35 cases), received allopurinol treatment, and the observation group (33 cases) treated with Febuxostat. The clinical effects, blood rheology and the changes of platelet activation function were compared between the two groups. Results The total effective rate of the observation group was significantly higher than that of the control group (P<0.05). Compared with the control group, the improvement of blood rheology and platelet activation function in the observation group were more significant than those in the control group (P<0.05). Conclusion Febuxostat therapy can effectively reduce uric acid level in patients with gout and hyperuricemia; improve blood rheology and platelet activation function in patients with gout and hyperuricemia, and the curative effect is better than that of allopurinol.